Jose Daniel Subiela
@josedsh
Urologist, PhD. Urooncology. Kidney transplant. Hospital Universitario Ramon y Cajal. IRYCIS. Universidad de Alcalá. Ass. Edi @actasurologicas
ID: 78646593
30-09-2009 16:37:42
1,1K Tweet
942 Followers
777 Following
🎯 Masterclass in Urothelial Cancer !! Today March 7th great programe and excellent international (Dr. Bishoy M. Faltas Matt Galsky Bernadett Szabados Vadim Koshkin MD) and national experts (Óscar Rodríguez Faba Javier Puente Teresa Alonso Gordoa MJosé Juan ) invited to discuss new updates!!
Elevate your surgical skills to the next level! Our #PartialNephrectomy training models are here to help. Affordable, effective, and ready for you. Learn more: urology3d.com #TrainingForEveryone #urology3D Ricardo Brime Esther Garcia Rojo
Publicamos en marzo actasurologicas un fántastico estudio que demuestra que la litotricia es un tratamiento vigente y analiza factores de retratamiento y complicaciones. Validez actual de la litotricia extracorpórea como tratamiento de prim... sciencedirect.com/science/articl…
El próximo mes celebramos la 2ªEd #UrologyLunch! 🗓️18 de abril 15:30 h 🏥 #HospitalGregorioMarañon Salón de Actos de H. Materno Infantil ✏️Curso gratuito Os esperamos!!!!! soc.urológica.madrid #AstellasPharma #Recordati #AlterMedica #Salvat #ItaiPharma uromadrid.es/urology-lunch-…
Our team #EAU24 👏👏👏 David D'Andrea for Winning the European Association of Urology (EAU) Hans Marberger🏆 with a multicentric RCT on #ERBT vs standard #TURBT EAU Young Urologists Juan Gómez Rivas Marco Moschini Francesco Del Giudice Ekaterina Laukhtina Benjamin Pradere francesco soria Gautier Marcq Luca Afferi Jose Daniel Subiela Roberto Contieri
After 5 months, Finally! Here's our opinion piece on UGN-102 reverse thermal gel as a chemo ablation agent for intermediate risk bladder cancer. It will get interesting as TAR-210 delivery system will join this space soon. Felipe Villacampa tau.amegroups.org/article/view/1…
Is there a role for BCG in very high-risk non-muscle invasive bladder carcinoma? multicenter analysis of oncological outcomes and risk dynamics. Presented by Jose Daniel Subiela. #EAU24 written coverage by Zach Klaassen Georgia Cancer Center > bit.ly/4ag6NO1 European Association of Urology (EAU)
¡Arranca el Congreso de la Sociedad Gallega de Urología! 🎉 Empezamos con la IV Reunión de Inmunoterapia en Uro-oncología. Interesantes discusiones sobre inmunoterapia en TVNMI, Ca renal y manejo de las toxicidades. Sociedad Gallega de Urología Dario Vazquez-Martul Maxi Castro Jose Daniel Subiela
Espléndida tarde pensando en la inmunoterapia de los cánceres urológicos con Manuel Carballo Jose Daniel Subiela y el Dr. Álvarez Osorio. Organizado por Sociedad Gallega de Urología Dario Vazquez-Martul
Checkout the latest issue June 2024 actasurologicas in ScienceDirect sciencedirect.com/journal/actas-…
In @UroToday: @Urodocash chats with Jose Daniel Subiela about Dr. Subiela's multicenter study on BCG therapy for very high-risk non-muscle-invasive bladder cancer. Click here to watch the video: urotoday.com/video-lectures…
Adequate BCG therapy for very high-risk #NMIBC. Jose Daniel Subiela joins Ashish M. Kamat, MD, MBBS to discuss findings from a study that underscore the importance of tailored treatment approaches and the need for continuous follow-up to refine patient management strategies > bit.ly/3YrhkmA